# Comorbidities in Weight-Loss Drug Users: Norwegian Registry of 190,818 Starters

Norwegian registries compared earlier diagnoses and medicine dispensing in 190,818 weight-loss drug starters and matched controls.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/the-customer-is-sicker-than-the-ad
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Comorbidities in Weight-Loss Drug Users: Norwegian Registry of 190,818 Starters

A Norwegian registry study found more recorded coexisting conditions among people starting a weight-loss drug than among age- and sex-matched controls.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20267 min readUpdated November 2026

Users vs matched controls · users · controls · any comorbidity · 74% · 50% · hypertension · 35% · 18% · opioid dispensed · 27% · 14% · antidepressant · 22% · 10% · sleep apnea · 9% · 2% · Midpoints of ranges spanning five different drugs.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

Studies of [who receives GLP-1 treatment](https://buythisglp.com/research/who-the-price-filtered-out) can reflect different health systems. Researchers used Norwegian registries to describe what diagnoses people had before starting one of five weight-loss medicines [\[1\]](https://buythisglp.com/research/the-customer-is-sicker-than-the-ad#ref-1).

## Who was included

The study followed adults aged 18 to 74 who started one of the medicines in 2023 or 2024 (n = 190,818). Researchers matched each to five population controls by age and sex. They checked diagnoses from the prior two years and medicines dispensed in the prior year.

Between 71% and 78% of starters had at least one recorded coexisting condition. Among controls, the range was 49% to 51%. The ranges show variation across the five drug groups [\[1\]](https://buythisglp.com/research/the-customer-is-sicker-than-the-ad#ref-1).

## Which conditions were recorded

High blood pressure was recorded in 32% to 38% of starters and 17% to 20% of controls. The corresponding ranges for sleep apnea were 7% to 11% and 2% to 3%.

Trials of [GLP-1 treatment for sleep apnea](https://buythisglp.com/research/do-glp1-drugs-help-sleep-apnea) ask a different question about treatment outcomes. This registry study measured diagnoses that preceded treatment.

Opioids and antidepressants were also dispensed more often before treatment in the starter groups. Dispensing records cannot confirm why a drug was prescribed or whether it was taken. The Norwegian results do not establish the health profile of U.S. telehealth patients.

## Frequently asked

What percentage had a coexisting condition?

Across the five drug groups, 71% to 78% of starters had at least one recorded condition. The matched control groups ranged from 49% to 51%.

## Sources

1.  \[1\] Bakken IJ, Ruiz PL, Furu K, Gulseth HL, et al. (2026). Clinical Characteristics of Users of Weight Loss Drugs: Population-Based Case-Control Study Diabetes, Obesity & Metabolism. [PMID 42086462](https://doi.org/10.1111/dom.70827)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
